We will be exhibiting some touch samples of our synthetic artificial dura mater “DuraBeam®” at the Gunze Medical Co., Ltd. booth at STROKE2025 (50th Annual Meeting of the Japan Stroke Society; Thursday, March 6th to Saturday, March 8th, 2025) (Chairman: Kazunori Toyoda, Vice Director of the National Cerebral and Cardiovascular Center, Location: Osaka International Convention Center).
https://site.convention.co.jp/stroke2025
https://site.convention.co.jp/kjjsc2025
TamaBio Company Limited
Head Office : 402 Gran Creste 2-2-18 Sakai Musashino-shi Tokyo 180-0022 Japan
Medical device manufacturing / Class 1 manufacturing and sales Development
Manufacturing, and sales of Class IV highly controlled medical devices
(dura mater and pericardial prosthesis material)
Development, manufacturing, and sales of regenerative medical devices and other synthetic artificial biomembranes
Managing Director / CEO : Tetsuya Nagao
TEL : +81-422-53-5051 / FAX : +81-422-38-5091